Find relevant news articles from other European projects, below:
Browse our carefully curated library of the latest news and developments in all areas of immunotherapy here:
Tisagenlecleucel Leads to High CR Rate in Heavily Pretreated, R/R Follicular Lym...
Tisagenlecleucel induced a significant number of complete responses in patients with relapsed or refractory follicular lymphoma, meeting the primary end point of the phase 2 ELARA trial as of the interim analysis of the study.
PRWCC: Disease burden impacts outcomes in paediatric and young adult B-Cell ALL ...
Dr Schultz talks to ecancer about disease burden impacts outcomes in pediatric and young adult B-cell acute lymphoblastic leukaemia after commercial tisagenlecleucel: Results from the paediatric real world CAR consortium (PRWCC). These results were presented at this year’s ASH 2020 virtual conference.